IP Library Granted Patent US 9,400,241
Granted Patent B2
US 9,400,241 · App. 14/166,327 · Granted Jul 26, 2016

Solute concentration measurement device and related methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,400,241
App. No.
14/166,327
Granted
Jul 26, 2016
Kind
B2
Abstract

A solute concentration measurement device is disclosed. The device may comprise a filter membrane, an exchange chamber, a sensing chamber, a separator, and a sensor. The device may be configured to be placed in fluid communication with a sample solution containing a solute and a solvent. The filter membrane may provide selective fluid communication between the solution and the exchange chamber. The separator may separate the exchange chamber from the sensing chamber and cause a change in a condition of the sensing chamber corresponding to a change of a condition of the exchange chamber. The sensor may sense the condition pertaining to the sensing chamber and calculate the concentration of the sample solution corresponding to this change.

Claims (30)

1. A method comprising, providing a combination, the combination comprising:

an exchange chamber;

a sensing chamber containing a compressible fluid;

a filter membrane configured to provide selective fluid communication between a sample solution and the exchange chamber when the filter membrane is in fluid communication with the sample solution, the filter membrane substantially impermeable to a solute contained in the exchange chamber;

a movable separator configured to separate the exchange chamber from the sensing chamber; and

a pressure sensor adapted to measure a pressure of the compressible fluid in the sensing chamber.

2. The method of claim 1 , further comprising:

providing a calibration sample of known concentration for determining an amount of solute in the exchange chamber.

3. The method of claim 1 , further comprising providing instructions for using the combination to determine a physical condition within a patient.

4. The method of claim 3 , wherein the instructions include implanting the combination in the patient's body.

5. The method of claim 3 , wherein the instructions comprise putting the combination into contact with a bodily fluid of the patient such that the bodily fluid function as the sample solution.

6. The method of claim 5 , wherein putting the combination into contact with a bodily fluid of the patient includes putting the combination into contact with interstitial fluid of the patient.

7. The method of claim 5 , wherein the instructions comprise determining a glucose concentration in the bodily fluid.

8. The method of claim 5 , wherein the instructions comprise determining the physical condition when a concentration of the solute in the exchange chamber reaches equilibrium with a concentration of the solute in the bodily fluid.

9. The method of claim 5 , wherein the instructions comprise determining the physical condition prior to a concentration of the solute in the exchange chamber reaching equilibrium with a concentration of the solute in the bodily fluid the bodily fluid.

10. The method of claim 9 , wherein determining the physical condition prior to the concentration of the solute in the exchange chamber reaching equilibrium with the concentration of the solute in the bodily fluid includes fitting a change in concentration of the solute in the exchange chamber to a curve of known behavior.

11. A method comprising:

placing a solute concentration measurement device comprising a housing having disposed therein at least an exchange chamber, a sensing chamber containing a compressible fluid and having a pressure sensor adapted to measure a pressure of the compressible fluid, a filter membrane substantially impermeable to a solute in the exchange chamber and a movable separator disposed between the exchange chamber and the sensing chamber into fluid communication with a sample solution;

measuring the pressure of the compressible fluid in the sensing chamber; and

using the measured pressure in the sensing chamber to calculate the concentration of the solute in the sample solution.

12. The method of claim 11 , further comprising:

determining an amount of the solute in the exchange chamber prior to placing the solute concentration measurement device into fluid communication with the sample solution.

13. The method of claim 11 , further comprising using the calculation of the concentration of the solute in the sample solution to determine a physical condition within a patient.

14. The method of claim 13 , further comprising implanting the solute concentration measurement device in the patient's body.

15. The method of claim 13 , wherein the sample solution is a bodily fluid of the patient.

16. The method of claim 15 , wherein the bodily fluid of the patient is interstitial fluid of the patient.

17. The method of claim 15 , wherein the solute is glucose and determining a physical condition within the patient includes determining a glucose concentration in the bodily fluid.

18. The method of claim 15 , wherein the physical condition is determined when a concentration of the solute in the exchange chamber reaches equilibrium with a concentration of the solute in the bodily fluid.

19. The method of claim 15 , wherein the physical condition is determined prior to a concentration of the solute in the exchange chamber reaching equilibrium with a concentration of the solute in the bodily fluid the bodily fluid.

20. The method of claim 19 , wherein determining the physical condition prior to the concentration of the solute in the exchange chamber reaching equilibrium with the concentration of the solute in the bodily fluid includes fitting a change in concentration of the solute in the exchange chamber to a curve of known behavior.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Mar 24, 2024
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: TANDEM DIABETES CARE, INC.
Reel/Frame 066880/0918 →
SECURITY INTEREST Recorded May 25, 2022
From: TANDEM DIABETES CARE, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 060179/0100 →
RELEASE OF SECURITY INTEREST Recorded Aug 10, 2018
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II L.P. - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II (CAYMAN) L.P.
To: TANDEM DIABETES CARE, INC.
Reel/Frame 046761/0843 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 14, 2014
From: BROWN, DAVID
To: TANDEM DIABETES CARE, INC.
Reel/Frame 032668/0510 →
SHORT-FORM PATENT SECURITY AGREEMENT Recorded Apr 4, 2014
From: TANDEM DIABETES CARE, INC.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II (CAYMAN) L.P.
Reel/Frame 032608/0780 →